Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The genetic polymorphisms of HER-2 and the risk of lung cancer in a Korean population.

BMC cancer - 4 Dec 2008

Jo Uk Hyun, Han Sle Gi Lo, Seo Jae Hong, Park Kyong Hwa, Lee Jae Won, Lee Hyo Jung, Ryu Jeong Seon, Kim Yeul Hong

Abstract excerpt

BACKGROUND: Human Epidermal Growth Factor Receptor 2 (HER-2; also known as erbB-2 or neu), a proto-oncogene of the receptor tyrosine kinase superfamily, has been associated with carcinogenesis and prognosis of human cancers, acting as a binding partner of other epidermal growth factor receptor (EGFR) family in the activation of EGFR signaling. Amplification of the HER-2 gene has been reported in lung cancer,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alcohol Drinking
Share to Korea
Share to Lung Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Polymorphism, Genetic

Share to Proto-Oncogene Mas

Share to Receptor, ErbB-2

Share to Risk Factors

Share to Smoking

Source

Open in PubMed Open full text

Identifiers

PMID: 19055823
DOI: 10.1186/1471-2407-8-359
PMCID: PMC2661000

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The genetic polymorphisms of HER-2 and the risk of lung cancer in a Korean population.PMID 19055823Read ↗

Epidemiological study of HER-2 mutations among EGFR wild-type lung adenocarcinoma patients in China.Semantic proximity Read ↗

[Current management and future prospect of HER-2 mutant non-small cell lung cancer].Semantic proximity Read ↗

HER2 mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation Consortium.Semantic proximity Read ↗

[Role of HER2 in NSCLC].Semantic proximity Read ↗

Somatic mutations of the HER2 kinase domain in lung adenocarcinomas.Semantic proximity Read ↗

Prognostic and predictive implications of HER2/ERBB2/neu gene mutations in lung cancers.Semantic proximity Read ↗

EGFR and ERBB2 Germline Mutations in Chinese Lung Cancer Patients and Their Roles in Genetic Susceptibility to CancerSemantic proximity Read ↗

HER2 and lung cancer.Semantic proximity Read ↗

Association of an EGFR intron 1 SNP with never-smoking female lung adenocarcinoma patients.Semantic proximity Read ↗

HER2 mutations in Chinese patients with non-small cell lung cancer.Semantic proximity Read ↗

Polymorphisms in the epidermal growth factor receptor gene and the risk of primary lung cancer: a case-control study.Semantic proximity Read ↗

Comparable clinical outcomes in patients with HER2-mutant and EGFR-mutant lung adenocarcinomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.